{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:30:28Z","timestamp":1789086628575,"version":"build-2803163510"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T00:00:00Z","timestamp":1461196800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"grant from Association des Amis de la Facult\u00e9 de m\u00e9dicine de Nice"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00345-016-1826-2","type":"journal-article","created":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T07:27:33Z","timestamp":1461223653000},"page":"337-353","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review"],"prefix":"10.1007","volume":"35","author":[{"given":"Aur\u00e9lie","family":"Mbeutcha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish M.","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Lawrentschuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Novara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay D.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanguelos","family":"Xylinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,21]]},"reference":[{"key":"1826_CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65:5\u201329","journal-title":"CA Cancer J Clin"},{"key":"1826_CR2","doi-asserted-by":"publisher","unstructured":"Roupr\u00eat M et al (2015) European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 update. Eur Urol doi: 10.1016\/j.eururo.2015.06.044","DOI":"10.1016\/j.eururo.2015.06.044"},{"key":"1826_CR3","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1464-410X.2012.11341.x","volume":"110","author":"BP Rai","year":"2012","unstructured":"Rai BP, Shelley M, Coles B, Somani B, Nabi G (2012) Surgical management for upper urinary tract transitional cell carcinoma (UUT-TCC): a systematic review. BJU Int 110:1426\u20131435","journal-title":"BJU Int"},{"key":"1826_CR4","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.urology.2012.12.059","volume":"81","author":"A Bagrodia","year":"2013","unstructured":"Bagrodia A et al (2013) Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma. Urology 81:972\u2013977","journal-title":"Urology"},{"key":"1826_CR5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.eururo.2012.02.018","volume":"62","author":"M Rink","year":"2012","unstructured":"Rink M et al (2012) Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery. Eur Urol 62:677\u2013684","journal-title":"Eur Urol"},{"key":"1826_CR6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2012.02.030","volume":"62","author":"G Lughezzani","year":"2012","unstructured":"Lughezzani G et al (2012) Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol 62:100\u2013114","journal-title":"Eur Urol"},{"key":"1826_CR7","unstructured":"Committee 2, Roupr\u00eat M, Kamat A, Karakiewicz P, Khochikar M, Lawrentschuk N, Novara G, Raman JD, Schwentner C, Seitz C, Stephenson A, Thompson H, Xylinas E, Shariat SF (2014) Prognostics factors and predictive tools in UTUC. In: Shariat SF, Matin S, Stenzl A (eds) Upper tract urothelial carcinoma. Soci\u00e9t\u00e9 Internationale d\u2019Urologie Montr\u00e9al, QC, pp 51\u201375"},{"key":"1826_CR8","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B et al (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Int Med 162:777\u2013784","journal-title":"Ann Int Med"},{"key":"1826_CR9","unstructured":"OCEBM Levels of Evidence Working Group\u00a0=\u00a0Jeremy Howick, Iain Chalmers (James Lind Library), Paul Glasziou, Trish Greenhalgh, Carl Heneghan, Alessandro Liberati, Ivan Moschetti, Bob Phillips, Hazel Thornton, O. G. and M. H. OCEBM Levels of Evidence Working Group. \u2018The Oxford Levels of Evidence 2\u2019. Oxford Centre for Evidence-Based Medicine. http:\/\/www.cebm.net\/index.aspx?o=5653"},{"key":"1826_CR10","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","volume":"107","author":"JD Raman","year":"2011","unstructured":"Raman JD, Messer J, Sielatycki JA, Hollenbeak CS (2011) Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973\u20132005. BJU Int 107:1059\u20131064","journal-title":"BJU Int"},{"key":"1826_CR11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1464-410X.2011.10288.x","volume":"109","author":"RL Favaretto","year":"2012","unstructured":"Favaretto RL et al (2012) Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. BJU Int 109:77\u201382","journal-title":"BJU Int"},{"key":"1826_CR12","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.urolonc.2011.07.011","volume":"31","author":"JC Messer","year":"2013","unstructured":"Messer JC et al (2013) Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma. Urol Oncol 31:904\u2013908","journal-title":"Urol Oncol"},{"key":"1826_CR13","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/bju.12238","volume":"112","author":"X-P Chen","year":"2013","unstructured":"Chen X-P et al (2013) Predictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experience from a nationwide high-volume centre in China. BJU Int 112:917\u2013924","journal-title":"BJU Int"},{"key":"1826_CR14","first-page":"1","volume":"10","author":"H Yeh","year":"2015","unstructured":"Yeh H, Jan H, Wu W, Li C (2015) Concurrent preoperative presence of hydronephrosis and flank pain independently predicts worse outcome of upper tract urothelial carcinoma. PLoS One 10:1\u201313","journal-title":"PLoS One"},{"key":"1826_CR15","first-page":"1082","volume":"63","author":"M Rink","year":"2012","unstructured":"Rink M et al (2012) Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy. BJU Int 63:1082\u20131090","journal-title":"BJU Int"},{"key":"1826_CR16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bju.12400","volume":"114","author":"E Xylinas","year":"2014","unstructured":"Xylinas E et al (2014) Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy. BJU Int 114:56\u201361","journal-title":"BJU Int"},{"key":"1826_CR17","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1464-410X.2009.09072.x","volume":"105","author":"SF Shariat","year":"2010","unstructured":"Shariat SF et al (2010) Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int 105:1672\u20131677","journal-title":"BJU Int"},{"key":"1826_CR18","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00345-011-0677-0","volume":"29","author":"TF Chromecki","year":"2011","unstructured":"Chromecki TF et al (2011) Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy. World J Urol 29:473\u2013480","journal-title":"World J Urol"},{"key":"1826_CR19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.urology.2011.03.032","volume":"78","author":"SA Yap","year":"2011","unstructured":"Yap SA, Schupp CW, Chamie K, Evans CP, Koppie TM (2011) Effect of age on transitional cell carcinoma of the upper urinary tract: presentation, treatment, and outcomes. Urology 78:87\u201392","journal-title":"Urology"},{"key":"1826_CR20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.urology.2009.09.048","volume":"75","author":"G Lughezzani","year":"2010","unstructured":"Lughezzani G et al (2010) Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the surveillance, epidemiology, and end results database. Urology 75:321\u2013327","journal-title":"Urology"},{"key":"1826_CR21","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.urolonc.2011.06.014","volume":"31","author":"Y Kusuda","year":"2013","unstructured":"Kusuda Y et al (2013) Gender as a significant predictor of intravesical recurrence in patients with urothelial carcinoma of the upper urinary tract following nephroureterectomy. Urol Oncol 31:899\u2013903","journal-title":"Urol Oncol"},{"key":"1826_CR22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00345-010-0594-7","volume":"29","author":"SF Shariat","year":"2011","unstructured":"Shariat SF et al (2011) Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol 29:481\u2013486","journal-title":"World J Urol"},{"key":"1826_CR23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.juro.2011.03.031","volume":"186","author":"B Ehdaie","year":"2011","unstructured":"Ehdaie B et al (2011) Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma. J Urol 186:66\u201372","journal-title":"J Urol"},{"key":"1826_CR24","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.urolonc.2009.11.007","volume":"29","author":"JD Raman","year":"2011","unstructured":"Raman JD et al (2011) Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy? Urol Oncol 29:716\u2013723","journal-title":"Urol Oncol"},{"key":"1826_CR25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.juro.2010.03.030","volume":"184","author":"JC Brien","year":"2010","unstructured":"Brien JC et al (2010) Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol 184:69\u201373","journal-title":"J Urol"},{"key":"1826_CR26","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.urolonc.2010.07.010","volume":"30","author":"H-M Fritsche","year":"2012","unstructured":"Fritsche H-M et al (2012) Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma. Urol Oncol 30:666\u2013672","journal-title":"Urol Oncol"},{"key":"1826_CR27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1464-410X.2008.08003.x","volume":"103","author":"M Remzi","year":"2009","unstructured":"Remzi M et al (2009) Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU Int 103:307\u2013311","journal-title":"BJU Int"},{"key":"1826_CR28","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.eururo.2011.05.049","volume":"60","author":"A Ouzzane","year":"2011","unstructured":"Ouzzane A et al (2011) Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy. Eur Urol 60:1258\u20131265","journal-title":"Eur Urol"},{"key":"1826_CR29","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00345-011-0645-8","volume":"29","author":"W Otto","year":"2011","unstructured":"Otto W et al (2011) Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients. World J Urol 29:487\u2013494","journal-title":"World J Urol"},{"key":"1826_CR30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.urolonc.2010.01.001","volume":"30","author":"JC Wheat","year":"2012","unstructured":"Wheat JC et al (2012) Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. Urol Oncol 30:252\u2013258","journal-title":"Urol Oncol"},{"key":"1826_CR31","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00345-013-1141-0","volume":"32","author":"A Masson-Lecomte","year":"2014","unstructured":"Masson-Lecomte A et al (2014) Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol 32:531\u2013537","journal-title":"World J Urol"},{"issue":"204","key":"1826_CR32","first-page":"e9","volume":"33","author":"Y Shibing","year":"2015","unstructured":"Shibing Y et al (2015) Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy. Urol Oncol 33(204):e9\u2013e16","journal-title":"Urol Oncol"},{"key":"1826_CR33","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.juro.2012.04.009","volume":"188","author":"M Rink","year":"2012","unstructured":"Rink M et al (2012) Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. J Urol 188:398\u2013404","journal-title":"J Urol"},{"key":"1826_CR34","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/bju.12116","volume":"111","author":"S Hurel","year":"2013","unstructured":"Hurel S et al (2013) Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy. BJU Int 111:1199\u20131207","journal-title":"BJU Int"},{"key":"1826_CR35","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.eururo.2009.12.029","volume":"57","author":"G Novara","year":"2010","unstructured":"Novara G et al (2010) Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. Eur Urol 57:1064\u20131071","journal-title":"Eur Urol"},{"key":"1826_CR36","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2008.17.2361","volume":"27","author":"E Kikuchi","year":"2009","unstructured":"Kikuchi E et al (2009) Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 27:612\u2013618","journal-title":"J Clin Oncol"},{"key":"1826_CR37","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.eururo.2009.11.035","volume":"57","author":"R Zigeuner","year":"2010","unstructured":"Zigeuner R et al (2010) Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol 57:575\u2013581","journal-title":"Eur Urol"},{"key":"1826_CR38","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.juro.2010.06.106","volume":"184","author":"C Seitz","year":"2010","unstructured":"Seitz C et al (2010) Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study. J Urol 184:1895\u20131900","journal-title":"J Urol"},{"key":"1826_CR39","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.juro.2009.07.035","volume":"182","author":"H Isbarn","year":"2009","unstructured":"Isbarn H et al (2009) Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma. J Urol 182:2177\u20132181","journal-title":"J Urol"},{"key":"1826_CR40","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.eururo.2009.07.002","volume":"57","author":"JD Raman","year":"2010","unstructured":"Raman JD et al (2010) Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. Eur Urol 57:1072\u20131079","journal-title":"Eur Urol"},{"key":"1826_CR41","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.eururo.2010.07.003","volume":"58","author":"RL Favaretto","year":"2010","unstructured":"Favaretto RL et al (2010) The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol 58:574\u2013580","journal-title":"Eur Urol"},{"key":"1826_CR42","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.juro.2010.03.142","volume":"184","author":"V Margulis","year":"2010","unstructured":"Margulis V et al (2010) Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol 184:453\u2013458","journal-title":"J Urol"},{"key":"1826_CR43","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1038\/srep06361","volume":"4","author":"Y Wu","year":"2014","unstructured":"Wu Y, Dong Q, Liu L, Han P, Wei Q (2014) The impact of tumor location and multifocality on prognosis for patients with upper tract urothelial carcinoma: a meta-analysis. Sci Rep 4:6361","journal-title":"Sci Rep"},{"key":"1826_CR44","first-page":"4829","volume":"35","author":"J Liu","year":"2015","unstructured":"Liu J et al (2015) Prognostic impact of ALDH1 expression in transitional cell carcinoma of the renal pelvis. Anticancer Res 35:4829\u20134836","journal-title":"Anticancer Res"},{"key":"1826_CR45","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.juro.2014.11.007","volume":"193","author":"L-M Krabbe","year":"2015","unstructured":"Krabbe L-M et al (2015) Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract. J Urol 193:1486\u20131493","journal-title":"J Urol"},{"key":"1826_CR46","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.juro.2013.07.012","volume":"191","author":"L-M Krabbe","year":"2014","unstructured":"Krabbe L-M et al (2014) Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma. J Urol 191:28\u201334","journal-title":"J Urol"},{"key":"1826_CR47","first-page":"710","volume":"7","author":"I-W Chang","year":"2015","unstructured":"Chang I-W et al (2015) CDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder. Am J Transl Res 7:710\u2013722","journal-title":"Am J Transl Res"},{"key":"1826_CR48","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jjco\/hyu163","volume":"45","author":"K Kuroda","year":"2015","unstructured":"Kuroda K et al (2015) Clinical significance of p21-activated kinase 1 expression level in patients with upper urinary tract urothelial carcinoma. Jpn J Clin Oncol 45:103\u2013110","journal-title":"Jpn J Clin Oncol"},{"key":"1826_CR49","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/jso.23836","volume":"111","author":"H-Y Lee","year":"2015","unstructured":"Lee H-Y et al (2015) INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract. J Surg Oncol 111:414\u2013422","journal-title":"J Surg Oncol"},{"key":"1826_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.05.101","author":"H-C Yeh","year":"2015","unstructured":"Yeh H-C et al (2015) PTP4A3 independently predicts metastasis and survival in upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol. doi: 10.1016\/j.juro.2015.05.101","journal-title":"J Urol"},{"key":"1826_CR51","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/01.ju.0000148272.77539.2d","volume":"173","author":"Y Miyata","year":"2005","unstructured":"Miyata Y, Kanda S, Nomata K, Eguchi J, Kanetake H (2005) Expression of cyclooxygenase-2 and EP4 receptor in transitional cell carcinoma of the upper urinary tract. J Urol 173:56\u201360","journal-title":"J Urol"},{"key":"1826_CR52","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.urology.2014.07.050","volume":"84","author":"A Bagrodia","year":"2014","unstructured":"Bagrodia A et al (2014) Evaluation of the prognostic significance of altered mammalian target of rapamycin pathway biomarkers in upper tract urothelial carcinoma. Urology 84:1134\u20131140","journal-title":"Urology"},{"key":"1826_CR53","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1038\/bjc.2013.216","volume":"108","author":"S Yoshimine","year":"2013","unstructured":"Yoshimine S et al (2013) Prognostic significance of Bcl-xL expression and efficacy of Bcl-xL targeting therapy in urothelial carcinoma. Br J Cancer 108:2312\u20132320","journal-title":"Br J Cancer"},{"key":"1826_CR54","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1245\/s10434-014-3503-2","volume":"21","author":"T Ichimura","year":"2014","unstructured":"Ichimura T et al (2014) Prognostic significance of CD204-positive macrophages in upper urinary tract cancer. Ann Surg Oncol 21:2105\u20132112","journal-title":"Ann Surg Oncol"},{"key":"1826_CR55","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.eururo.2007.09.036","volume":"52","author":"K Bensalah","year":"2007","unstructured":"Bensalah K, Montorsi F, Shariat SF (2007) Challenges of cancer biomarker profiling. Eur Urol 52:1601\u20131609","journal-title":"Eur Urol"},{"key":"1826_CR56","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1245\/s10434-014-3830-3","volume":"21","author":"N Tanaka","year":"2014","unstructured":"Tanaka N et al (2014) A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy. Ann Surg Oncol 21:4041\u20134048","journal-title":"Ann Surg Oncol"},{"key":"1826_CR57","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.juro.2013.10.073","volume":"191","author":"M Pichler","year":"2014","unstructured":"Pichler M et al (2014) Validation of the preoperative plasma fibrinogen level as a prognostic factor in a European cohort of patients with localized upper tract urothelial carcinoma. J Urol 191:920\u2013925","journal-title":"J Urol"},{"key":"1826_CR58","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.eururo.2013.09.003","volume":"65","author":"E Xylinas","year":"2014","unstructured":"Xylinas E et al (2014) Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool. Eur Urol 65:650\u2013658","journal-title":"Eur Urol"},{"key":"1826_CR59","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/bju.12707","volume":"115","author":"J Ishioka","year":"2015","unstructured":"Ishioka J et al (2015) Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy. BJU Int 115:705\u2013712","journal-title":"BJU Int"},{"key":"1826_CR60","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.eururo.2012.01.021","volume":"61","author":"EK Cha","year":"2012","unstructured":"Cha EK et al (2012) Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol 61:818\u2013825","journal-title":"Eur Urol"},{"key":"1826_CR61","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.eururo.2012.01.019","volume":"62","author":"SF Shariat","year":"2012","unstructured":"Shariat SF et al (2012) Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification. Eur Urol 62:224\u2013231","journal-title":"Eur Urol"},{"key":"1826_CR62","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","volume":"115","author":"V Margulis","year":"2009","unstructured":"Margulis V et al (2009) Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration. Cancer 115:1224\u20131233","journal-title":"Cancer"},{"key":"1826_CR63","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1016\/j.ejca.2013.04.016","volume":"49","author":"JH Ku","year":"2013","unstructured":"Ku JH et al (2013) Lymphovascular invasion as a prognostic factor in the upper urinary tract urothelial carcinoma: a systematic review and meta-analysis. Eur J Cancer 49:2665\u20132680","journal-title":"Eur J Cancer"},{"key":"1826_CR64","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/bju.12014","volume":"112","author":"M Rink","year":"2013","unstructured":"Rink M et al (2013) Gender-specific effect of smoking on upper tract urothelial carcinoma outcomes. BJU Int 112:623\u2013637","journal-title":"BJU Int"},{"key":"1826_CR65","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejso.2013.09.016","volume":"40","author":"M Rieken","year":"2014","unstructured":"Rieken M et al (2014) Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Eur J Surg Oncol 40:113\u2013120","journal-title":"Eur J Surg Oncol"},{"key":"1826_CR66","first-page":"1","volume":"2015","author":"C-Y Hu","year":"2015","unstructured":"Hu C-Y et al (2015) Ureteral involvement and diabetes increase the risk of subsequent bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma. Biomed Res Int 2015:1\u20138","journal-title":"Biomed Res Int"},{"key":"1826_CR67","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/dmrr.2614","volume":"31","author":"Y-S Tai","year":"2015","unstructured":"Tai Y-S et al (2015) Quality assessment and improvement in diabetes care-an issue now and for the future. Diabetes. Metab Res Rev 31:307\u2013314","journal-title":"Diabetes. Metab Res Rev"},{"key":"1826_CR68","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.eururo.2014.11.035","volume":"67","author":"T Seisen","year":"2015","unstructured":"Seisen T et al (2015) A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma. Eur Urol 67:1122\u20131133","journal-title":"Eur Urol"},{"key":"1826_CR69","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.urolonc.2014.01.022","volume":"32","author":"H Yuan","year":"2014","unstructured":"Yuan H et al (2014) Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis. Urol Oncol Semin Orig Investig 32:989\u20131002","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"1826_CR70","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/bjc.2011.565","volume":"106","author":"N Tanaka","year":"2012","unstructured":"Tanaka N et al (2012) Prognonstic impact of renin-angiotensin system blockade in localised upper-tract urothelial carcinoma. Br J Cancer 106:290\u2013296","journal-title":"Br J Cancer"},{"key":"1826_CR71","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00345-012-0964-4","volume":"31","author":"G Bozzini","year":"2013","unstructured":"Bozzini G et al (2013) Influence of preoperative hydronephrosis on the outcome of urothelial carcinoma of the upper urinary tract after nephroureterectomy: the results from a multi-institutional French cohort. World J Urol 31:83\u201391","journal-title":"World J Urol"},{"key":"1826_CR72","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.urolonc.2011.12.004","volume":"31","author":"AK Williams","year":"2013","unstructured":"Williams AK et al (2013) Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma. Urol Oncol 31:1161\u20131165","journal-title":"Urol Oncol"},{"key":"1826_CR73","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.juro.2007.01.030","volume":"177","author":"JWF Catto","year":"2007","unstructured":"Catto JWF et al (2007) Behavior of urothelial carcinoma with respect to anatomical location. J Urol 177:1715\u20131720","journal-title":"J Urol"},{"key":"1826_CR74","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/j.1464-410X.2012.11108.x","volume":"110","author":"M Kates","year":"2012","unstructured":"Kates M, Badalato GM, Gupta M, McKiernan JM (2012) Secondary bladder cancer after upper tract urothelial carcinoma in the US population. BJU Int 110:1325\u20131329","journal-title":"BJU Int"},{"key":"1826_CR75","doi-asserted-by":"crossref","first-page":"845","DOI":"10.5489\/cuaj.1985","volume":"8","author":"A Kapoor","year":"2014","unstructured":"Kapoor A et al (2014) The impact of method of distal ureter management during radical nephroureterectomy on tumour recurrence. Can Urol Assoc J 8:845\u2013852","journal-title":"Can Urol Assoc J"},{"key":"1826_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.11.036","author":"T Seisen","year":"2015","unstructured":"Seisen T et al (2015) Oncological outcomes of radical nephroureterectomy versus kidney-sparing surgery for elective treatment of clinically organ-confined upper tract urothelial carcinoma of the distal ureter. J Urol. doi: 10.1016\/j.juro.2015.11.036","journal-title":"J Urol"},{"key":"1826_CR77","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.eururo.2012.04.052","volume":"65","author":"E Xylinas","year":"2014","unstructured":"Xylinas E et al (2014) Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol 65:210\u2013217","journal-title":"Eur Urol"},{"key":"1826_CR78","doi-asserted-by":"publisher","DOI":"10.1111\/his.12778","author":"I-W Chang","year":"2015","unstructured":"Chang I-W et al (2015) BCAT1 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder. Histopathology. doi: 10.1111\/his.12778","journal-title":"Histopathology"},{"key":"1826_CR79","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-015-1522-7","author":"I-W Chang","year":"2015","unstructured":"Chang I-W et al (2015) GPX2 underexpression indicates poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder. World J Urol. doi: 10.1007\/s00345-015-1522-7","journal-title":"World J Urol"},{"key":"1826_CR80","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s10147-014-0695-1","volume":"20","author":"K Fujita","year":"2015","unstructured":"Fujita K et al (2015) Preoperative risk stratification for cancer-specific survival of patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy. Int J Clin Oncol 20:156\u2013163","journal-title":"Int J Clin Oncol"},{"key":"1826_CR81","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3892\/mco.2015.553","volume":"3","author":"Y Luo","year":"2015","unstructured":"Luo Y, Fu SJ, She DL, Xiong HU, Yang LI (2015) Preoperative C-reactive protein as a prognostic predictor for upper tract urothelial carcinoma: a systematic review and meta-analysis. Mol Clin Oncol 3:924\u2013928","journal-title":"Mol Clin Oncol"},{"issue":"48","key":"1826_CR82","first-page":"e19","volume":"32","author":"N Tanaka","year":"2014","unstructured":"Tanaka N et al (2014) The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: a multi-institutional study. Urol Oncol 32(48):e19\u2013e26","journal-title":"Urol Oncol"},{"key":"1826_CR83","first-page":"1435","volume":"11","author":"B Ehdaie","year":"2014","unstructured":"Ehdaie B, Shariat SF, Savage C, Coleman J, Dalbagni G (2014) Postoperative nomogram for disease recurrence and cancer-specific death for upper tract urothelial carcinoma: comparison to American Joint Committee on Cancer staging classification. Urol J 11:1435\u20131441","journal-title":"Urol J"},{"key":"1826_CR84","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s00345-015-1566-8","volume":"33","author":"RF Youssef","year":"2015","unstructured":"Youssef RF et al (2015) TALL score for prediction of oncological outcomes after radical nephroureterectomy for high-grade upper tract urothelial carcinoma. World J Urol 33:1965\u20131972","journal-title":"World J Urol"},{"key":"1826_CR85","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00345-013-1116-1","volume":"32","author":"P Colin","year":"2014","unstructured":"Colin P et al (2014) Risk stratification of metastatic recurrence in invasive upper urinary tract carcinoma after radical nephroureterectomy without lymphadenectomy. World J Urol 32:507\u2013512","journal-title":"World J Urol"},{"key":"1826_CR86","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1464-410X.2006.06524.x","volume":"98","author":"GA Brown","year":"2006","unstructured":"Brown GA et al (2006) Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm? BJU Int 98:1176\u20131180","journal-title":"BJU Int"},{"key":"1826_CR87","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1464-410X.2011.10479.x","volume":"109","author":"JI Martinez-Salamanca","year":"2012","unstructured":"Martinez-Salamanca JI et al (2012) Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study. BJU Int 109:1155\u20131161","journal-title":"BJU Int"},{"key":"1826_CR88","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1464-410X.2011.10188.x","volume":"108","author":"K Matsumoto","year":"2011","unstructured":"Matsumoto K et al (2011) Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study. BJU Int 108:304\u2013309","journal-title":"BJU Int"},{"key":"1826_CR89","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.eururo.2009.12.001","volume":"57","author":"G Lughezzani","year":"2010","unstructured":"Lughezzani G et al (2010) Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study. Eur Urol 57:956\u2013962","journal-title":"Eur Urol"},{"key":"1826_CR90","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1111\/j.1464-410X.2011.10792.x","volume":"110","author":"FA Yafi","year":"2012","unstructured":"Yafi FA et al (2012) Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy. BJU Int 110:E7\u2013E13","journal-title":"BJU Int"},{"key":"1826_CR91","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-4781-z","author":"Y Cheng","year":"2015","unstructured":"Cheng Y, Huang C, Wu W, Li C (2015) The prognostic significance of inflammation-associated blood cell markers in patients with upper tract urothelial carcinoma. Ann Surg Oncol. doi: 10.1245\/s10434-015-4781-z","journal-title":"Ann Surg Oncol"},{"key":"1826_CR92","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1002\/cncr.25122","volume":"116","author":"C Jeldres","year":"2010","unstructured":"Jeldres C et al (2010) Highly predictive survival nomogram after upper urinary tract urothelial carcinoma. Cancer 116:3774\u20133784","journal-title":"Cancer"},{"key":"1826_CR93","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/bju.12631","volume":"114","author":"T Seisen","year":"2014","unstructured":"Seisen T et al (2014) Postoperative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localised and\/or locally advanced upper tract urothelial carcinoma without metastasis. BJU Int 114:733\u2013740","journal-title":"BJU Int"},{"key":"1826_CR94","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.juro.2012.10.057","volume":"189","author":"M Roupr\u00eat","year":"2013","unstructured":"Roupr\u00eat M et al (2013) Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis. J Urol 189:1662\u20131669","journal-title":"J Urol"},{"key":"1826_CR95","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/bjc.2013.462","volume":"109","author":"JH Ku","year":"2013","unstructured":"Ku JH et al (2013) External validation of an online nomogram in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma. Br J Cancer 109:1130\u20131136","journal-title":"Br J Cancer"},{"key":"1826_CR96","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/bjc.2012.64","volume":"106","author":"DR Yates","year":"2012","unstructured":"Yates DR et al (2012) Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram. Br J Cancer 106:1083\u20131088","journal-title":"Br J Cancer"},{"key":"1826_CR97","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.urology.2010.09.032","volume":"77","author":"RF Youssef","year":"2011","unstructured":"Youssef RF, Shariat SF, Lotan Y, et al (2011) Prognostic effect of urinary bladder carcinoma in situ on clinical outcome of subsequent upper tract urothelial carcinoma. Urology 77:861\u2013866. doi: 10.1016\/j.urology.2010.09.032","journal-title":"Urology"},{"key":"1826_CR98","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.eururo.2011.09.017","volume":"61","author":"TF Chromecki","year":"2012","unstructured":"Chromecki TF, Cha EK, Fajkovic H, et al (2012) The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Eur Urol 61:245\u2013253. doi: 10.1016\/j.eururo.2011.09.017","journal-title":"Eur Urol"},{"key":"1826_CR99","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-015-1715-0","author":"Q Tang","year":"2015","unstructured":"Tang Q, Xiong G, Li X, et al (2015) The prognostic impact of squamous and glandular differentiation for upper tract urothelial carcinoma patients after radical nephroureterectomy. World J Urol. doi: 10.1007\/s00345-015-1715-0","journal-title":"World J Urol"},{"key":"1826_CR100","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.juro.2015.01.073","volume":"194","author":"EW Fan","year":"2015","unstructured":"Fan EW, Li C, Wu W, et al (2015) FGF7 over expression is an independent prognosticator in patients with urothelial carcinoma of the upper urinary tract and bladder. J Urol 194:223\u2013229. doi: 10.1016\/j.juro.2015.01.073","journal-title":"J Urol"},{"key":"1826_CR101","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1136\/jclinpath-2012-201278","volume":"66","author":"P-I Liang","year":"2013","unstructured":"Liang P-I, Wang Y-H, Wu T-F, et al (2013) IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder. J Clin Pathol 66:573\u2013582. doi: 10.1136\/jclinpath-2012-201278","journal-title":"J Clin Pathol"},{"key":"1826_CR102","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.eururo.2013.12.008","volume":"66","author":"DJ Lee","year":"2014","unstructured":"Lee DJ, Xylinas E, Rieken M, et al (2014) Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma. Eur Urol 66:379\u2013385. doi: 10.1016\/j.eururo.2013.12.008","journal-title":"Eur Urol"},{"key":"1826_CR103","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/s12885-015-1369-8","volume":"15","author":"B Shi","year":"2015","unstructured":"Shi B, Su B, Fang D, et al (2015) High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. BMC Cancer 15:380. doi: 10.1186\/s12885-015-1369-8","journal-title":"BMC Cancer"},{"key":"1826_CR104","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/bju.12551","volume":"113","author":"L Izquierdo","year":"2014","unstructured":"Izquierdo L, Ingelmo-Torres M, Mallofre C, et al (2014) Prognostic value of microRNA expression pattern in upper tract urothelial carcinoma. BJU Int 113:813\u2013821. doi: 10.1111\/bju.12551","journal-title":"BJU Int"},{"key":"1826_CR105","first-page":"2447","volume":"5","author":"H Ke","year":"2015","unstructured":"Ke H, Lin H, Li W, et al (2015) High visfatin expression predicts poor prognosis of upper tract urothelial carcinoma patients. Am J Cancer Res 5:2447\u20132454","journal-title":"Am J Cancer Res"},{"key":"1826_CR106","doi-asserted-by":"publisher","unstructured":"Pignot G, Colin P, Zerbib M, et al (2014) Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma. Urol Oncol 32:23.e1\u20138. doi: 10.1016\/j.urolonc.2012.08.010","DOI":"10.1016\/j.urolonc.2012.08.010"},{"key":"1826_CR107","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1245\/s10434-014-4302-5","volume":"22","author":"D Fang","year":"2015","unstructured":"Fang D, Zhang L, Li X, et al (2015) Presence of concomitant non-muscle-invasive bladder cancer in chinese patients with upper tract urothelial carcinoma: risk factors, characteristics, and predictive value. Ann Surg Oncol 22:2789\u20132798. doi: 10.1245\/s10434-014-4302-5","journal-title":"Ann Surg Oncol"},{"key":"1826_CR108","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00345-012-0983-1","volume":"31","author":"A Ouzzane","year":"2013","unstructured":"Ouzzane A, Colin P, Ghoneim TP, et al (2013) The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy. World J Urol 31:189\u2013197. doi: 10.1007\/s00345-012-0983-1","journal-title":"World J Urol"},{"key":"1826_CR109","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1245\/s10434-012-2453-9","volume":"19","author":"P Colin","year":"2012","unstructured":"Colin P, Ouzzane A, Yates DR, et al (2012) Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival. Ann Surg Oncol 19:3613\u20133620. doi: 10.1245\/s10434-012-2453-9","journal-title":"Ann Surg Oncol"},{"key":"1826_CR110","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/jjco\/hyu020","volume":"44","author":"S Hamada","year":"2014","unstructured":"Hamada S, Horiguchi A, Asano T, et al (2014) Prognostic impact of fatty acid synthase expression in upper urinary tract urothelial carcinoma. Jpn J Clin Oncol 44:486\u2013492. doi: 10.1093\/jjco\/hyu020","journal-title":"Jpn J Clin Oncol"},{"key":"1826_CR111","first-page":"699","volume":"7","author":"Y Sasaki","year":"2014","unstructured":"Sasaki Y, Sasaki T, Kawai T, et al (2014) HER2 protein overexpression and gene amplification in upper urinary tract urothelial carcinoma-an analysis of 171 patients. Int J Clin Exp Pathol 7:699\u2013708","journal-title":"Int J Clin Exp Pathol"},{"key":"1826_CR112","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1158\/1078-0432.CCR-04-1685","volume":"11","author":"K Nakanishi","year":"2005","unstructured":"Nakanishi K, Hiroi S, Tominaga S, et al (2005) Expression of hypoxia-inducible factor-1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract. Clin Cancer Res 11:2583\u20132590. doi: 10.1158\/1078-0432.CCR-04-1685","journal-title":"Clin Cancer Res"},{"key":"1826_CR113","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/jjco\/hyv139","volume":"45","author":"P Wu","year":"2015","unstructured":"Wu P, Liu S, Zhang W, et al (2015) Low-level Ki-67 expression as an independent predictor of bladder tumour recurrence in patients with primary upper tract urothelial carcinoma after radical nephroureterectomy. Jpn J Clin Oncol 45:1175\u20131181. doi: 10.1093\/jjco\/hyv139","journal-title":"Jpn J Clin Oncol"},{"key":"1826_CR114","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.clgc.2012.12.009","volume":"11","author":"JH Ku","year":"2013","unstructured":"Ku JH, Byun S-S, Jeong H, et al (2013) The role of p53 on survival of upper urinary tract urothelial carcinoma: a systematic review and meta-analysis. Clin Genitourin Cancer 11:221\u2013228. doi: 10.1016\/j.clgc.2012.12.009","journal-title":"Clin Genitourin Cancer"},{"key":"1826_CR115","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-015-1484-9","author":"M Kim","year":"2015","unstructured":"Kim M, Moon KC, Choi WS, et al (2015) Prognostic value of systemic inflammatory responses in patients with upper urinary tract urothelial carcinoma. World J Urol. doi: 10.1007\/s00345-015-1484-9","journal-title":"World J Urol"},{"key":"1826_CR116","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1464-410X.2008.07988.x","volume":"103","author":"C Bolenz","year":"2009","unstructured":"Bolenz C, Shariat SF, Fern\u00e1ndez MI, et al (2009) Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density. BJU Int 103:302\u2013306. doi: 10.1111\/j.1464-410X.2008.07988.x","journal-title":"BJU Int"},{"key":"1826_CR117","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-4848-x","author":"S Hattori","year":"2015","unstructured":"Hattori S, Kikuchi E, Kosaka T, Miyazaki Y (2015) Relationship between increased expression of the Axl \/ Gas6 signal cascade and prognosis of patients with upper tract urothelial carcinoma. Ann Surg Oncol. doi: 10.1245\/s10434-015-4848-x","journal-title":"Ann Surg Oncol"},{"key":"1826_CR118","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.eururo.2008.06.013","volume":"55","author":"JMM Oers van","year":"2009","unstructured":"van Oers JMM, Zwarthoff EC, Rehman I, et al (2009) FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours. Eur Urol 55:650\u2013657. doi: 10.1016\/j.eururo.2008.06.013","journal-title":"Eur Urol"},{"key":"1826_CR119","doi-asserted-by":"publisher","unstructured":"Jeon HG, Jeong IG, Bae J, et al (2010) Expression of Ki-67 and COX-2 in patients with upper urinary tract urothelial carcinoma. Urology 76:513.e7\u2013513.e12. doi: 10.1016\/j.urology.2010.03.070","DOI":"10.1016\/j.urology.2010.03.070"},{"key":"1826_CR120","first-page":"2439","volume":"30","author":"L Izquierdo","year":"2010","unstructured":"Izquierdo L, Truan D, Mengual L, et al (2010) HER-2\/AKT expression in upper urinary tract urothelial carcinoma: prognostic implications. Anticancer Res 30:2439\u20132445","journal-title":"Anticancer Res"},{"key":"1826_CR121","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.urolonc.2009.10.009","volume":"29","author":"H-L Ke","year":"2011","unstructured":"Ke H-L, Chang L-L, Yang S-F, et al (2011) Osteopontin overexpression predicts poor prognosis of upper urinary tract urothelial carcinoma. Urol Oncol 29:703\u2013709. doi: 10.1016\/j.urolonc.2009.10.009","journal-title":"Urol Oncol"},{"key":"1826_CR122","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/1471-2407-10-164","volume":"10","author":"T Kamai","year":"2010","unstructured":"Kamai T, Shirataki H, Nakanishi K, et al (2010) Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer. BMC Cancer 10:164. doi: 10.1186\/1471-2407-10-164","journal-title":"BMC Cancer"},{"key":"1826_CR123","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1245\/s10434-013-3259-0","volume":"20","author":"S Sakano","year":"2013","unstructured":"Sakano S, Matsuyama H, Kamiryo Y, et al (2013) Risk group stratification based on preoperative factors to predict survival after nephroureterectomy in patients with upper urinary tract urothelial carcinoma. Ann Surg Oncol 20:4389\u20134396. doi: 10.1245\/s10434-013-3259-0","journal-title":"Ann Surg Oncol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-016-1826-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-016-1826-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-016-1826-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-016-1826-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T18:07:10Z","timestamp":1718474830000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-016-1826-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,21]]},"references-count":123,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["1826"],"URL":"https:\/\/doi.org\/10.1007\/s00345-016-1826-2","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,21]]}}}